Thyquidity patents expiration

THYQUIDITY's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050307 AZURITY Method for the preparation of a levothyroxine solution
Aug, 2031

(7 years from now)

Thyquidity is owned by Azurity.

Thyquidity contains Levothyroxine Sodium.

Thyquidity has a total of 1 drug patent out of which 0 drug patents have expired.

Thyquidity was authorised for market use on 30 November, 2020.

Thyquidity is available in solution;oral dosage forms.

The generics of Thyquidity are possible to be released after 06 August, 2031.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 30 November, 2020

Treatment: NA


How can I launch a generic of THYQUIDITY before it's drug patent expiration?
More Information on Dosage

THYQUIDITY family patents

Family Patents